Forum Financial Management LP boosted its stake in Exelon Co. (NASDAQ:EXC – Free Report) by 16.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,177 shares of the company’s stock after purchasing an additional 1,154 shares during the period. Forum Financial Management LP’s holdings in Exelon were worth $332,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Crewe Advisors LLC bought a new stake in shares of Exelon in the 1st quarter worth approximately $26,000. American National Bank & Trust boosted its position in shares of Exelon by 178.8% during the third quarter. American National Bank & Trust now owns 697 shares of the company’s stock valued at $28,000 after purchasing an additional 447 shares in the last quarter. Versant Capital Management Inc boosted its position in shares of Exelon by 646.2% during the second quarter. Versant Capital Management Inc now owns 776 shares of the company’s stock valued at $27,000 after purchasing an additional 672 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in shares of Exelon during the second quarter valued at approximately $28,000. Finally, Abound Wealth Management boosted its holdings in Exelon by 502.7% in the second quarter. Abound Wealth Management now owns 892 shares of the company’s stock worth $31,000 after acquiring an additional 744 shares in the last quarter. 80.92% of the stock is currently owned by institutional investors.
Exelon Stock Down 0.5 %
Shares of NASDAQ:EXC opened at $37.97 on Tuesday. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. The stock has a market cap of $38.15 billion, a P/E ratio of 15.63, a price-to-earnings-growth ratio of 2.84 and a beta of 0.54. The business’s 50 day moving average is $39.66 and its 200 day moving average is $37.74. Exelon Co. has a 52-week low of $33.35 and a 52-week high of $41.42.
Exelon Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Monday, November 11th will be given a $0.38 dividend. The ex-dividend date of this dividend is Friday, November 8th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 4.00%. Exelon’s payout ratio is 62.55%.
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. Barclays boosted their price target on Exelon from $41.00 to $44.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Jefferies Financial Group assumed coverage on Exelon in a report on Thursday, September 19th. They set a “buy” rating and a $46.00 price target for the company. UBS Group upped their price objective on Exelon from $40.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday, September 20th. Scotiabank increased their price target on Exelon from $37.00 to $40.00 and gave the company a “sector perform” rating in a research note on Tuesday, August 20th. Finally, Morgan Stanley upped their price objective on Exelon from $42.00 to $45.00 and gave the company an “equal weight” rating in a research report on Wednesday, September 25th. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $41.33.
Get Our Latest Research Report on Exelon
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
- Five stocks we like better than Exelon
- 3 Small Caps With Big Return Potential
- Intel: Is Now the Time to Be Brave?Â
- Airline Stocks – Top Airline Stocks to Buy Now
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Which Wall Street Analysts are the Most Accurate?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.